NICHOLAS J Dawson FUGATE
- Type
- Physician · Allopathic & Osteopathic Physicians / Family Medicine
- Where
- Pineville, KY
- NPI
- 1477058071
- Received
- $1,326 in 68 records, 2021 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 22 | $458 |
| 2024 | General payment | 20 | $354 |
| 2023 | General payment | 12 | $267 |
| 2022 | General payment | 9 | $171 |
| 2021 | General payment | 5 | $76 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $304 | 2024–2025 |
| Novo Nordisk Inc | 4 | $178 | 2022–2025 |
| AstraZeneca Pharmaceuticals LP | 8 | $164 | 2021–2025 |
| Janssen Pharmaceuticals, Inc | 5 | $109 | 2022–2025 |
| ABBVIE INC. | 6 | $105 | 2022–2025 |
| Axsome Therapeutics, Inc. | 4 | $62 | 2024–2025 |
| Lilly USA, LLC | 4 | $61 | 2021–2023 |
| Merck Sharp & Dohme LLC | 3 | $56 | 2021–2023 |
| Vanda Pharmaceuticals Inc. | 3 | $54 | 2025 |
| PFIZER INC. | 3 | $45 | 2023 |
| GRT US Holding, Inc. | 1 | $45 | 2022 |
| Xeris Pharmaceuticals, Inc. | 2 | $32 | 2024 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 | 2024 |
| Gilead Sciences, Inc. | 1 | $21 | 2023 |
| Neurocrine BioSciences, Inc. | 1 | $20 | 2024 |
| Smith+Nephew, Inc. | 1 | $15 | 2024 |
| E.R. Squibb & Sons, L.L.C. | 1 | $13 | 2023 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $12 | 2021 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Food and Beverage | 67 | $1,277 |
| Education | 1 | $48 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $13 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-11 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-12-10 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $18 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-02 | AstraZeneca Pharmaceuticals LP | $19 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-12-02 | Vanda Pharmaceuticals Inc. | $18 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2025 | |
| 2025-11-25 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-13 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-28 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $15 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-22 | AstraZeneca Pharmaceuticals LP | $18 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-24 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $14 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-09-24 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $6 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-13 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-08-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $12 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-01 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $11 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-06-12 | Vanda Pharmaceuticals Inc. | $16 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2025 | |
| 2025-05-30 | Axsome Therapeutics, Inc. | $14 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-04-15 | Novo Nordisk Inc | $123 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-03-27 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $11 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-03-05 | Janssen Pharmaceuticals, Inc | $14 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-03-04 | Vanda Pharmaceuticals Inc. | $18 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2025 | |
| 2025-02-27 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-01-27 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | 2025 | ||
| 2024-11-11 | AstraZeneca Pharmaceuticals LP | $14 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-11-08 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-08-02 | Novo Nordisk Inc | $14 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-07-31 | Xeris Pharmaceuticals, Inc. | $17 | Food and Beverage | In-kind items and services | GVOKE HYPOPEN Drug, Diabetes | 2024 | |
| 2024-06-14 | Neurocrine BioSciences, Inc. | $20 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-06-10 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $15 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-05-24 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $10 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-05-24 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-05-08 | Xeris Pharmaceuticals, Inc. | $15 | Food and Beverage | In-kind items and services | GVOKE HYPOPEN Drug, Diabetes | 2024 | |
| 2024-05-07 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $13 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-05-03 | Axsome Therapeutics, Inc. | $14 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-04-03 | Novo Nordisk Inc | $15 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-03-14 | Otsuka America Pharmaceutical, Inc. | $25 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-03-08 | Axsome Therapeutics, Inc. | $16 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-02-08 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-01-27 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $11 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-01-26 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $48 | Education | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-01-25 | Axsome Therapeutics, Inc. | $16 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-01-13 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-01-03 | Smith+Nephew, Inc. | $15 | Food and Beverage | In-kind items and services | COLLAGENASE SANTYL Drug, Pharma Products | 2024 | |
| 2023-12-11 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-11-27 | E.R. Squibb & Sons, L.L.C. | $13 | Food and Beverage | Cash or cash equivalent | ELIQUIS Drug, Cardiovascular | 2023 | |
| 2023-11-21 | Janssen Pharmaceuticals, Inc | $26 | Food and Beverage | In-kind items and services | XARELTO Drug, Cardiovascular & Metabolism | 2023 | |
| 2023-11-08 | PFIZER INC. | $14 | Food and Beverage | In-kind items and services | ELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE | 2023 | |
| 2023-10-25 | AstraZeneca Pharmaceuticals LP | $50 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2023 | |
| 2023-10-17 | Janssen Pharmaceuticals, Inc | $17 | Food and Beverage | In-kind items and services | XARELTO Drug, Cardiovascular & Metabolism | 2023 | |
| 2023-09-15 | Janssen Pharmaceuticals, Inc | $33 | Food and Beverage | In-kind items and services | XARELTO Drug, Cardiovascular & Metabolism | 2023 | |
| 2023-09-13 | PFIZER INC. | $14 | Food and Beverage | In-kind items and services | PREMARIN Drug, WOMENS HEALTH | 2023 | |
| 2023-09-06 | Gilead Sciences, Inc. | $21 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-05-03 | PFIZER INC. | $16 | Food and Beverage | In-kind items and services | PREMARIN Drug, WOMENS HEALTH | 2023 | |
| 2023-03-16 | Lilly USA, LLC | $20 | Food and Beverage | In-kind items and services | EMGALITY Drug, Neuroscience | 2023 | |
| 2023-02-14 | Merck Sharp & Dohme LLC | $22 | Food and Beverage | In-kind items and services | STEGLATRO Drug, ENDOCRINOLOGY | 2023 | |
| 2022-12-15 | Janssen Pharmaceuticals, Inc | $18 | Food and Beverage | In-kind items and services | XARELTO Drug, Cardiovascular & Metabolism | 2022 | |
| 2022-11-08 | Lilly USA, LLC | $13 | Food and Beverage | In-kind items and services | TRULICITY Drug, Diabetes | 2022 | |
| 2022-09-27 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2022 | |
| 2022-09-06 | GRT US Holding, Inc. | $45 | Food and Beverage | In-kind items and services | Qutenza Drug, Pain Management | 2022 | |
| 2022-08-11 | AstraZeneca Pharmaceuticals LP | $15 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2022 | |
| 2022-03-04 | Novo Nordisk Inc | $24 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2022 | |
| 2022-02-11 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-02-03 | Lilly USA, LLC | $12 | Food and Beverage | In-kind items and services | TRULICITY Drug, Diabetes | 2022 | |
| 2022-02-01 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2021-11-30 | Lilly USA, LLC | $14 | Food and Beverage | In-kind items and services | TRULICITY Drug, Diabetes | 2021 | |
| 2021-11-17 | Merck Sharp & Dohme LLC | $17 | Food and Beverage | In-kind items and services | 2021 | ||
| 2021-11-09 | Boehringer Ingelheim Pharmaceuticals, Inc. | $12 | Food and Beverage | In-kind items and services | TRADJENTA Drug, DIABETES | 2021 | |
| 2021-10-12 | Merck Sharp & Dohme LLC | $17 | Food and Beverage | In-kind items and services | BELSOMRA Drug, NEUROSCIENCE | 2021 | |
| 2021-10-06 | AstraZeneca Pharmaceuticals LP | $14 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2021 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Pineville, KY, county Bell County, KY, state Kentucky; placed by its city name.
| Measure | Place (city or town) Pineville, KY | County Bell County, KY | State Kentucky |
|---|---|---|---|
| Population B01003 | 2,064 | 23,509 | 4,534,824 |
| Population, 2020 census P1 | 1,678 | 24,097 | 4,505,836 |
| Median age B01002 | 43.1 | 41.7 | 39.1 |
| Under 18 B01001 | 21.9% | 21.9% | 22.6% |
| 65 and over B01001 | 19.9% | 18.9% | 17.3% |
| Households B11001 | 909 | 9,939 | 1,814,469 |
| Foreign born B05002 | 0.0% | 0.4% | 4.7% |
| Median household income B19013 | $24,547 | $31,354 | $63,726 |
| Median family income B19113 | $41,481 | $47,097 | $81,505 |
| Per capita income B19301 | $23,589 | $21,704 | $35,821 |
| Poverty rate B17001 | 34.0% | 28.8% | 16.1% |
| Unemployment rate B23025 | 15.0% | 10.1% | 4.9% |
| Civilian labor force B23025 | 639 | 8,079 | 2,152,038 |
| Mean commute (minutes) B08013 | 20.5 | 22.7 | 24.0 |
| Bachelor's degree or higher B15003 | 19.8% | 15.8% | 27.6% |
| Housing units B25001 | 1,004 | 11,631 | 2,023,116 |
| Owner-occupied B25003 | 34.8% | 58.8% | 68.3% |
| Renters B25003 | 65.2% | 41.2% | 31.7% |
| Median home value B25077 | $98,700 | $89,000 | $205,600 |
| Median gross rent B25064 | $407 | $592 | $967 |
| White, not Hispanic B03002 | 90.7% | 92.6% | 81.5% |
| Black B03002 | 3.8% | 3.0% | 7.6% |
| Hispanic or Latino B03002 | 0.0% | 0.5% | 5.0% |
| Asian B03002 | 0.0% | 0.3% | 1.6% |
| American Indian and Alaska Native B03002 | 0.0% | 0.1% | 0.1% |
Economy now FRED unemployment 4.7% in Sep 2026 (4.5% a year earlier); per capita personal income $60,835 in 2025, up 29% in five years (+3.9% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Pineville, KY.
Comments